Forefront Analytics’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $262K | Buy |
|
|||||
|
2024
Q3 | $312K | Sell |
|
|||||
|
2024
Q2 | $345K | Sell |
|
|||||
|
2024
Q1 | $331K | Buy |
|
|||||
|
2023
Q4 | $280K | Buy |
|
|||||
|
2023
Q3 | $241K | Sell |
|
|||||
|
2023
Q2 | $245K | Sell |
|
|||||
|
2023
Q1 | $293K | Buy |
|
|||||
|
2022
Q4 | $221K | Sell |
|
|||||
|
2022
Q3 | $216K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $353K | Buy |
|
|||||
|
2021
Q4 | $249K | Buy |
|
|||||
|
2021
Q3 | $233K | Sell |
|
|||||
|
2021
Q2 | $235K | Sell |
|
|||||
|
2021
Q1 | $238K | Buy |
|